Skip to content

Clinical trials

Hemophilia B trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20123
20131
20143
20151
20171
20184
20191
20201
20211
20223
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting6
Terminated5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
CSL Behring4
ApcinteX Ltd3
Bioverativ Therapeutics Inc.3
Genzyme, a Sanofi Company2
Novo Nordisk A/S2
Bayer1
Bioverativ, a Sanofi company1
Regeneron Pharmaceuticals1
Spark Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B27
Hemophilia A15
Blood Coagulation Disorders4
Hematologic Diseases4
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders2
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Hemorrhage2
Hemorrhagic Disorders2

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.